Biocon Chief says Budget 2018 exhaustive and comprehensive

2018-02-01 10:21:12

\n\n\n \n \n \n \n\n\n\n

\nThe Union Budget 2018 was presented on February 1, 2018. Dr Kiran\nMazumdar-Shaw, chairperson ABLE and CMD Biocon, giving her initial\nreaction to the Budget commented, “This is the first time that any\nBudget covers the Healthcare needs of half of India’s population.”

Read more

SRMCRI, MedGenome set up genomics centre in Chennai

2018-02-01 06:41:35

The Sri Ramachandra Medical College and Research Institute (SRMCRI) and MedGenome have launched a new genomics center in Chennai.By Team ABLEThe Sri Ramachandra Medical College and Research Institute (SRMCRI) and MedGenome, one of the global leaders in research and diagnostics, have announced the launch of a new genomics center in Chennai.The centre located at the SRMCRI in Porur, would provide an

Read more

ICMR, Pfizer collaborate to work on antimicrobial resistance

2018-02-01 06:40:25

ICMR and Pfizer have collaborated to set up a Centre to Combat Antimicrobial Resistance in New Delhi.By Team ABLEThe Indian Council of Medical Research (ICMR) and biopharma giant Pfizer have collaborated to set up a centre to address the growing threat of antimicrobial resistance in India. The Centre to Combat Antimicrobial Resistance in New Delhi will be set up as a part of memorandum of understa

Read more

Elsevier welcomes six biotech and pharma start-ups to The Hive

2018-02-01 06:37:39

Start-ups working on a range of  technologies and discoveries, from AI to immunotherapy, receive complimentary access to Elsevier\'s information solutions to accelerate innovation. By Team ABLEElsevier, the global information analytics business specializing in science and health, has announced that six start-up companies have been selected from more than 150 global applicants for The Hive, El

Read more

High levels of antibiotic resistance found worldwide: reveals WHO’s new data

2018-02-01 06:31:16

WHO\'s new Global Antimicrobial Surveillance System reveals widespread occurrence of antibiotic resistance among 500,000 people with suspected bacterial infections across 22 countries.By Team ABLEWHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.WHO’s new Global

Read more

C-CAMP\'s Meet the Investors Series to be held on Feb 15th at New Delhi

2018-02-01 06:28:52

This series will give the bio-entrepreneurs, who are looking to raise funding, an opportunity to pitch their business proposal to a panel of investors.By Team ABLE‘Meet the Investors Series’ is a series of quarterly meetings between investors and start-up bio-entrepreneurs. This series will give the bio-entrepreneurs, who are looking to raise funding, an opportunity to pitch their business pro

Read more

Economic Survey of India 2017-18 has a chapter on \"Transforming Science and Technology in India\"

2018-01-30 09:39:11

Prof. K. VijayRaghavan, DBT secretary tweeted that The Economic Survey has a detailed section on science which is quite remarkable. The chapter mentions that about three-fifths of the public investment is spread over the key government science funding agencies like At omic Energy, Space, Earth Sciences, Science and Technology and Biotechnology. Given the country’s severe health challenges, the l

Read more

Sanofi to acquire Belgian biotech firm Ablynx for USD 4.8 billion

2018-01-30 08:34:08

By acquiring Ablynx, Sanofi will be expanding its portfolio of drugs in rare blood disorders. By Team ABLEFrance’s Sanofi has announced that the company has reached a deal to acquire Belgian biotech firm Ablynx that values the firm at USD 4.8 billion, beating out Danish rival Novo Nordisk for the nano-drug maker.Novo Nordisk earlier this month made a 2.6-billion-euro offer to buy the firm that i

Read more

Mylan, Biocon receive positive CHMP opinion for Semglee

2018-01-30 08:33:17

Mylan and Biocon have received European Medicines Agency\'s positive opinion, recommending approval of Semglee, insulin glargine, a long-acting insulin analog used in the treatment of diabetes mellitusBy Team ABLEGlobal biopharmaceutical companies, Mylan N.V. and Biocon Ltd. have announced that the European Medicines Agency\'s Committee for Medicinal Products for Human Use (CHMP) has issued a posi

Read more

Cipla, Strides Shasun ship generic versions of Gilead Sciences’ HIV drug Viread

2018-01-30 08:32:32

Indian pharmaceutical companies, Cipla and Strides Shasun have started shipping generic versions of Gilead Sciences’ HIV drug Viread after its patent protection expired last week.By Team ABLEIndian pharmaceutical companies, Cipla and Strides Shasun have started shipping generic versions of Gilead Sciences’ HIV drug Viread after its patent protection expired last week.Cipla said that it has rec

Read more